The Claim
The association between targeting systolic blood pressure below 120 mm Hg and reduced mortality in adults with increased cardiovascular risk is highly sensitive to the inclusion of the SPRINT trial, such that its removal results in statistical non-significance.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with high cardiovascular risk, the observed link between lowering systolic blood pressure below 120 mm Hg and lower death rates depends entirely on one major study called SPRINT; without that study, the link disappears.
See the scientific wording
In adults with increased cardiovascular risk, the association between targeting systolic blood pressure below 120 mm Hg and reduced mortality is highly sensitive to the inclusion of the SPRINT trial, as its removal renders the result statistically non-significant, indicating that the overall finding is driven by a single large study.
Lowering blood pressure below 120 mm Hg reduces force on artery walls, which decreases damage to blood vessels and organs like the heart and kidneys, leading to fewer fatal complications.
What the research says
1 studyThis study looked at five big trials, not just one, and found that lowering blood pressure below 120 still saved lives — so it’s not just one study (SPRINT) making the difference.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.